Login / Signup

Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis.

Chun-Hung SuKuang-Hua HuangYih YangShuo-Yan GauNing-Jen ChungPo-Tseng WuTung-Han TsaiChien-Ying Lee
Published in: The journal of allergy and clinical immunology. In practice (2024)
Patients with allergic rhinitis on FGAs or SGAs face an escalating dementia risk with increasing cumulative dosage. Moreover, FGAs exhibit a higher dementia risk compared with SGAs. Nevertheless, extensive clinical trials are imperative for confirming the association between FGA use, SGA use, and dementia risk.
Keyphrases
  • allergic rhinitis
  • mild cognitive impairment
  • cognitive impairment
  • clinical trial
  • phase ii
  • double blind